Instil Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021
Market Capitalization	65	50	82	2,206
Market Cap Growth	-18.28%	-39.38%	-96.29%	-
Enterprise Value	-4	-18	-102	1,752
PE Ratio	-	-0.32	-0.37	-14.07
PB Ratio	0.32	0.22	0.23	3.97
P/FCF Ratio	-0.95	-0.48	-0.31	-12.26
P/OCF Ratio	-1.14	-0.60	-0.45	-18.06
EV/EBITDA Ratio	-0.01	0.12	0.47	-11.38
EV/EBIT Ratio	0.00	0.12	0.46	-11.18
EV/FCF Ratio	-0.01	0.18	0.38	-9.73
Debt / Equity Ratio	0.41	0.37	0.21	-
Debt / EBITDA Ratio	-0.75	-0.58	-0.36	-
Debt / FCF Ratio	-1.14	-0.82	-0.29	-
Quick Ratio	13.55	14.38	7.96	10.98
Current Ratio	14.19	15.23	8.22	11.22
Interest Coverage	-17.82	-28.96	-118.62	-
Return on Equity (ROE)	-51.30%	-58.50%	-51.30%	-25.50%
Return on Assets (ROA)	-35.70%	-41.60%	-41.60%	-23.90%
Return on Capital (ROIC)	-43.00%	-51.32%	-51.34%	-28.02%
Earnings Yield	-188.86%	-314.94%	-272.97%	-7.11%
FCF Yield	-113.26%	-207.21%	-323.82%	-8.16%
Buyback Yield / Dilution	-0.44%	-22.19%	-562.55%
Total Shareholder Return	-0.44%	-22.19%	-562.55%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).